BHC.TO vs. GUD.TO
BHC.TO (Bausch Health Companies Inc.) and GUD.TO (Knight Therapeutics Inc.) are both stocks. Both operate in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Over the past 10 years, BHC.TO returned -14.97%/yr vs -0.02%/yr for GUD.TO. At a 0.20 correlation, their price movements are largely independent.
Performance
BHC.TO vs. GUD.TO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BHC.TO achieves a -23.29% return, which is significantly lower than GUD.TO's 39.83% return. Over the past 10 years, BHC.TO has underperformed GUD.TO with an annualized return of -14.97%, while GUD.TO has yielded a comparatively higher -0.02% annualized return.
BHC.TO
- 1D
- 5.94%
- 1M
- -5.31%
- YTD
- -23.29%
- 6M
- -23.93%
- 1Y
- 15.30%
- 3Y*
- -11.84%
- 5Y*
- -28.02%
- 10Y*
- -14.97%
GUD.TO
- 1D
- 1.81%
- 1M
- 12.65%
- YTD
- 39.83%
- 6M
- 39.83%
- 1Y
- 40.53%
- 3Y*
- 20.13%
- 5Y*
- 9.97%
- 10Y*
- -0.02%
BHC.TO vs. GUD.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BHC.TO Bausch Health Companies Inc. | -23.29% | -17.99% | 9.31% | 25.06% | -75.67% | 32.30% | -32.06% | 53.94% | -3.63% | 34.57% |
GUD.TO Knight Therapeutics Inc. | 39.83% | 13.30% | 2.89% | 0.19% | -2.26% | -0.93% | -29.42% | -1.43% | -7.46% | -22.63% |
Correlation
The correlation between BHC.TO and GUD.TO is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Mar 4, 2014 | 0.20 |
Fundamentals
BHC.TO:
CA$2.71B
GUD.TO:
CA$836.92M
BHC.TO:
-CA$3.21
GUD.TO:
CA$0.06
BHC.TO:
0.31
GUD.TO:
1.65
BHC.TO:
CA$8.76B
GUD.TO:
CA$510.45M
BHC.TO:
CA$6.65B
GUD.TO:
CA$190.52M
BHC.TO:
CA$5.26B
GUD.TO:
CA$65.18M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BHC.TO vs. GUD.TO — Risk / Return Rank
BHC.TO
GUD.TO
BHC.TO vs. GUD.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bausch Health Companies Inc. (BHC.TO) and Knight Therapeutics Inc. (GUD.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BHC.TO | GUD.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.60 | ||
| Sortino ratioReturn per unit of downside risk | -2.43 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.37 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | 0.37 | 3.77 | -3.41 |
| Martin ratioReturn relative to average drawdown | 0.62 | 7.21 | -6.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BHC.TO | GUD.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.30 | 1.89 | -1.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.46 | 0.42 | -0.88 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.25 | -0.00 | -0.25 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 0.25 | -0.12 |
Drawdowns
BHC.TO vs. GUD.TO - Drawdown Comparison
The maximum BHC.TO drawdown since its inception was -98.41%, which is greater than GUD.TO's maximum drawdown of -60.09%. Use the drawdown chart below to compare losses from any high point for BHC.TO and GUD.TO.
Loading charts...
Drawdown Indicators
| BHC.TO | GUD.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.41% | -60.09% | -38.32% |
Max Drawdown (1Y)Largest decline over 1 year | -40.80% | -12.08% | -28.72% |
Max Drawdown (3Y)Largest decline over 3 years | -58.12% | -17.58% | -40.54% |
Max Drawdown (5Y)Largest decline over 5 years | -85.80% | -29.61% | -56.19% |
Max Drawdown (10Y)Largest decline over 10 years | -87.23% | -60.09% | -27.14% |
Current DrawdownCurrent decline from peak | -97.89% | -22.39% | -75.50% |
Average DrawdownAverage peak-to-trough decline | -56.54% | -34.48% | -22.06% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.09% | 6.31% | +17.78% |
Volatility
BHC.TO vs. GUD.TO - Volatility Comparison
Bausch Health Companies Inc. (BHC.TO) and Knight Therapeutics Inc. (GUD.TO) have volatilities of 13.30% and 13.21%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BHC.TO | GUD.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.30% | 13.21% | +0.09% |
Volatility (6M)Calculated over the trailing 6-month period | 30.30% | 19.97% | +10.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.62% | 24.06% | +26.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 61.28% | 24.05% | +37.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 59.83% | 24.08% | +35.75% |
Dividends
BHC.TO vs. GUD.TO - Dividend Comparison
Neither BHC.TO nor GUD.TO has paid dividends to shareholders.
Financials
BHC.TO vs. GUD.TO - Financials Comparison
This section allows you to compare key financial metrics between Bausch Health Companies Inc. and Knight Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BHC.TO vs. GUD.TO - Profitability Comparison
BHC.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bausch Health Companies Inc. reported a gross profit of 1.52B and revenue of 2.48B. Therefore, the gross margin over that period was 61.2%.
GUD.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Knight Therapeutics Inc. reported a gross profit of 54.44M and revenue of 148.44M. Therefore, the gross margin over that period was 36.7%.
BHC.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bausch Health Companies Inc. reported an operating income of 512.46M and revenue of 2.48B, resulting in an operating margin of 20.6%.
GUD.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Knight Therapeutics Inc. reported an operating income of 10.58M and revenue of 148.44M, resulting in an operating margin of 7.1%.
BHC.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bausch Health Companies Inc. reported a net income of -1.40B and revenue of 2.48B, resulting in a net margin of -56.4%.
GUD.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Knight Therapeutics Inc. reported a net income of 13.17M and revenue of 148.44M, resulting in a net margin of 8.9%.
Frequently Asked Questions
BHC.TO and GUD.TO have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for BHC.TO and GUD.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer